Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL

Detalles Bibliográficos
Autores principales: Khan, S., English, S., Hodgins, S., Lalu, M., Watpool, I., Champagne, J., Freund, D., Möbius, M. Alexander, Rüdiger, M., Fergusson, D., Thébaud, B., Stewart, D.J., Courtman, D.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023
Materias:
POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171026/
http://dx.doi.org/10.1016/S1465-3249(23)00242-6
Descripción
Sumario:

Ejemplares similares